Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr 26:7:34.
doi: 10.3389/fendo.2016.00034. eCollection 2016.

Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies

Affiliations
Review

Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies

Maria Felicia Faienza et al. Front Endocrinol (Lausanne). .

Abstract

Bone fragility is recognized as one of the major comorbidities in Turner syndrome (TS). The mechanisms underlying bone impairment in affected patients are not clearly elucidated, but estrogen deficiency and X-chromosomal abnormalities represent important factors. Moreover, although many girls with TS undergo recombinant growth hormone therapy to treat short stature, the efficacy of this treatment on bone mineral density is controversial. The present review will focus on bone fragility in subjects with TS, providing an overview on the pathogenic mechanisms and some prevention strategies.

Keywords: Turner syndrome; bone; bone mineral density; estrogens; fractures.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Potential mechanisms of bone fragility in Turner syndrome. (B) Monitoring and management of bone health in Turner syndrome.

References

    1. Wolff DJ, Van Dyke DL, Powell CM, Working Group of the ACMG Laboratory Quality Assurance Committee . Laboratory guideline for Turner syndrome. Genet Med (2010) 12:52–5. 10.1097/GIM.0b013e3181c684b2 - DOI - PubMed
    1. Bondy CA, Turner Syndrome Study Group . Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab (2007) 92:10–25. 10.1210/jc.2006-1374 - DOI - PubMed
    1. Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study. J Clin Endocrinol Metab (2002) 87:2798–808. 10.1210/jcem.87.6.8598 - DOI - PubMed
    1. Han TS, Cadge B, Conway GS. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner’s syndrome. Clin Endocrinol (2006) 65:643–7. 10.1111/j.1365-2265.2006.02643.x - DOI - PubMed
    1. Bakalov VK, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord (2008) 9:145–51. 10.1007/s11154-008-9076-2 - DOI - PubMed

LinkOut - more resources